Reshaping the HIV treatment and prevention landscape

New GSK to positively impact the health of >2.5 bn people over 10 years Estimated patient impact Vaccines* 1.3bn Specialty Medicines* 40m General Medicines 700m Global Health** Estimated total impact >2.5bn people over next 10 years, adjusting for category overlap; *Excludes COVID-19 vaccines or treatments; **Global Health includes donations Number of unique patients (m) Estimated global impact 1200 1000 800 600 400 200 1.2bn 0 Africa Asia & Pacific Europe Mid East & Arab States North America gsk South & Latin America 23

View entire presentation